FDA Moves to Restrict Abortion Pill Access
In an ominous move, the FDA — under pressure from antiabortion groups and GOP members of Congress — has launched a new safety study of mifepristone that is a thinly veiled move to restrict mail and telehealth access to the abortion pill. “The administration is aiming for a robust study that will withstand legal criticism,” … Read more